Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma
July 23, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first multi-site study in multiple myeloma (MM) comparing optical genome...
Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024
April 19, 2024 16:26 ET
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic...
Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs
June 09, 2022 09:38 ET
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, June 09, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
Cancer Immunotherapy Documentary Wins Prestigious Golden Owl Award at Bergen International Film Festival
October 08, 2019 09:00 ET
|
Uncommon Productions
Boston, MA, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (“Uncommon”) is proud to announce that their latest documentary, Jim Allison: Breakthrough (“Breakthrough”) has received the 2019...
Jim Allison: Breakthrough Documentary to Open in Theaters on September 27th
September 25, 2019 09:00 ET
|
Uncommon Productions
Boston, MA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Uncommon Productions (“Uncommon”) will premiere their latest documentary, Jim Allison: Breakthrough (“Breakthrough”) in New York and Los Angeles on...
National Brain Tumor Society & Memorial Sloan Kettering Agreement Bolsters Research Efforts to Combat Deadliest Brain Cancer
July 06, 2016 15:36 ET
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - July 06, 2016) - National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today announced that it has...